Home » Newsletters » BioWorld Science

BioWorld Science

April 4, 1997

View Archived Issues

New indication for liquid Nutropin approved by FDA

Digital Gene Technologies and Recordati collaborate on atherosclerosis research

Cubist prepares inhibitors of isoleucyl-tRNA synthetase

Novel antifungal discovered by Takara Shuzo

Anticarcinogenic 2-thioflavones from Taiho

SS Pharm. discloses platinum complexes

Mitsubishi Chemical isolates antihypertensive compound from natural source

Thymosin alpha 1 for DiGeorge syndrome

Novo Nordisk discloses metabotropic glutamate receptor antagonists

Schering-Plough claims adenosine A2a antagonists

Budesonide cleared in Canada for Crohn's disease

Shire's sustained-release carbamazepine deemed approvable by FDA

Gene therapy for radiation-induced salivary gland defects

Novel drug delivery system from Brown University shows promise

Annual Report: Emisphere Technologies

Company Profile: SangStat

Enzymes for anticancer drug design discovered and characterized

Company Profile: Oncogene Science

PPL Therapeutics produces salmon calcitonin in transgenic rabbits

Cortecs reports results with potential new class of anticancer compounds

GEM-91 associated with up to 90% decrease in cellular viremia in HIV-positive patients

Cardiosol associated with improved survival and reduced rejection in heart transplantation

Targeted Genetics' AAV vector useful for in vivo cardiovascular gene therapy

Antiangiogenic antibody from Ixsys enters clinical trials

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...